Navigation Links
Suntech to Attend Upcoming Investor Conferences and Industry Events
Date:9/4/2007

WUXI, China, Sept. 4 /Xinhua-PRNewswire/ -- Suntech Power Holdings Co., Ltd. (NYSE: STP), one of the world's leading manufacturers of photovoltaic (PV) cells and modules, today announced that management is scheduled to participate in the following upcoming investor conferences and industry events:

-- 22nd European Photovoltaic Conference on September 3-7, 2007 at the

Fiera Milano in Milan, Italy.

-- Cowen and Company Clean Energy Conference on September 6, 2007 at Le

Parker Meridien, New York.

-- Credit Suisse Asia Technology Conference on September 10, 2007 at

Crowne Plaza in Shenzhen, China and on September 13-14, 2007 at the

Grand Hyatt Taipei, Taiwan.

-- 14th CLSA Investors' Forum on September 17-21, 2007 at the Grand

Hyatt, Hong Kong.

-- ISES Solar World Congress 2007 on September 18-21, 2007 at the

Beijing International Convention Center in Beijing, China.

-- Solar Power 2007 on September 24-27, 2007 at the Long Beach

Convention and Entertainment Center in Long Beach, California.

-- Renewable Energy 2007 on October 10-12, 2007 in Makuhari, Japan.

-- Jefferies 4th Annual Global Clean Technology Conference on October

18, 2007 at the Claridge's Hotel in London.

Webcasts of select management presentations will be available on the "Investors" section of the Suntech website: http://www.suntech-power.com under "Events."

About Suntech

Suntech Power Holdings Co., Ltd. is a leading solar energy company in the world as measured by both production output and capacity of solar cells and modules. Suntech provides solar solutions for a
'/>"/>

SOURCE Suntech Power Holdings Co., Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Dispelling the top five myths about attending networking events
2. UW engineering career fair sees highest attendance in four years
3. Merge announces sofware updates, upcoming acquisition
4. Can tech people be business leaders? Upcoming seminar may have the answer
5. State of biotech, medical device sector is focus of upcoming conference
6. Telecom issues are among focus of upcoming western Wisconsin conference
7. Upcoming technology conferences look at government tech and RFID issues
8. Venture Investors early-stage fund grows to $115 million
9. Investor warns of angel-venture funding gap
10. Brazilian bio-industry should impress American investors
11. Investors raise $25 million for biodiesel plant

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...24/PRNewswire-FirstCall/-HamiltonThorneLtd.(TSX-V:...advancedlasersystemsandinstrumentsforthestemcellre...tionalandfinancialresultsforthethirdquarterendedSe...1.46millioncomparedwith$1.43millioninQ32008,-Gross...nQ3,2008,-Netlossreducedto$148,000comparedto$283,0...
(Date:11/24/2009)...--HealthRoboticstodayannounced,thatithasformedanew....ThisrecentlyformedToronto-basedcompanywilloperate...t,install,andsupport,HealthRobotics,i.v.RoomoftheF...offeringsi.v.STATION(TM),i.v.SOFT(TM),andOMM(TM).,...nan"asneeded,basis"toitsstrategicpartnershipswithM...
(Date:11/23/2009)...vocative new study, a University of Utah scientist...major cause of global warming cannot be stabilize...builds the equivalent of one new nuclear power pla...ll be any substantial near-term departure from rec...sion rates," says the new paper by Tim Garrett, an...
(Date:11/23/2009)...ire-FirstCall/--PDLBioPharma,Inc.(PDL)(Nasdaq: PDL...7,2009astheex-dividenddateforits$200millionspecial...ontransactioncompletedonNovember2,2009.Thedividend...rdontherecorddate,December1,2009.NASDAQhassettheap...eofcommonstockforpurposesoftheex-dividenddateonNov...
Breaking Biology Technology:Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2
... , , , , Multiporator / Electr... , , , Transformation... 01/2002 , , , , , ,... Microorganism , Pseudomonas aer...ype , Bacteria, gram negative, ...
... , , , , Multiporator / Electr... , , , Transformatio... 01/2002 , , , , , ,... Microorganism , Nocardia cora...e , Bacteria, gram positive, ,...
... , , , , Multiporator / Electr... , , , Transformatio... 03/2002 , , , , , ,... Microorganism , Mycobacterium... Cell type , Bacteria, gram positive,...
Other Biology Technology:Pseudomonas aeruginosa 2Nocardia corallina 2Mycobacterium smegmatis 2
(Date:11/23/2009)...160 participants gathered this week for the sevent...E conference. This year,s topic, "Synthetic Biolog...dical researchers to explore the engineering, scie... field of synthetic biology. , Bonnie L. Bassler...ersity and this year,s conference chair, challenge...
(Date:11/23/2009)...e vaccine available for the H1N1 virus has been se...us. The vaccination marks the first time vaccine h...ndemic flu., Iowa State University,s Hank Harris...ne this summer and has been shipping preventive do...s for several weeks., The latest vaccines were s...
(Date:11/23/2009)...study by University of Alabama at Birmingham (UAB)...co-existing medical conditions (co-morbidity) do n...frican-Americans compared to Caucasians who also h...v. 23 in Cancer , a journal of the American Cance... BMI and co-morbidity are independent predictors o...
Breaking Biology News(10 mins):Synthetic biology offers new opportunities for interdisciplinary collaboration 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Cadence Pharmaceuticals Announces Priority Review and Acceptance of NDA Submission for Acetavance 28TM 29 for Treatment of Acute Pain and Fever 51749 1Cadence Pharmaceuticals Announces Priority Review and Acceptance of NDA Submission for Acetavance 28TM 29 for Treatment of Acute Pain and Fever 51749 2Cadence Pharmaceuticals Announces Priority Review and Acceptance of NDA Submission for Acetavance 28TM 29 for Treatment of Acute Pain and Fever 51749 3Cadence Pharmaceuticals Announces Priority Review and Acceptance of NDA Submission for Acetavance 28TM 29 for Treatment of Acute Pain and Fever 51749 4Physician Hospitals 28PHA 29 Responds to TIME Magazine Article 3A Filled With Incorrect Assumption and Innuendo 51747 1Physician Hospitals 28PHA 29 Responds to TIME Magazine Article 3A Filled With Incorrect Assumption and Innuendo 51747 2Physician Hospitals 28PHA 29 Responds to TIME Magazine Article 3A Filled With Incorrect Assumption and Innuendo 51747 3Physician Hospitals 28PHA 29 Responds to TIME Magazine Article 3A Filled With Incorrect Assumption and Innuendo 51747 4China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 1China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 2China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 3China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 4China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 5China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 6China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 7China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 8China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 9China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 10China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 11China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 12China Biotics Inc Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results 13036 13
...p elucidate mechanisms of wake-sleep transitions a...sity of Pennsylvania School of Medicine have demon...called astrocytes are directly involved in regulat...ng of the study is that astrocytes modulate the le...h is thought to be important in controlling wake-t...
...scientists at UCSF sheds light on how the odor det...eir social behavior. , "Understanding how mice pr...tes the sense of smell--should provide insight int... use to transform sensory information into behavio...SF assistant professor of anatomy. , "There are s...
...ldiers guarding a castle gate, multiple genetic de...owdery mildew disease, according to a new study. P...ts that attacks more than 9,000 species, including...tural plants such as roses and cucumbers. The rese...ein of the Carnegie Institution,s Department of Pl...
Other Biology News:Penn study finds direct role for glial cells in brain cross-talk 2New study examines how sense of smell affects mating and aggression in mice 2Genetic defenders protect crops from fungal disease 2Genetic defenders protect crops from fungal disease 3
Acridine orange, hemizinc salt from Research Organics, Inc.
Acridine orange 10-nonyl bromide from AnaSpec
Anti-rat Ig HRP detection kit from BD Biosciences Pharmingen
Wash Solution from CHEMICON
Biology Products: